| Year |
Citation |
Score |
| 2015 |
McClay JL, Vunck SA, Batman AM, Crowley JJ, Vann RE, Beardsley PM, van den Oord EJ. Neurochemical Metabolomics Reveals Disruption to Sphingolipid Metabolism Following Chronic Haloperidol Administration. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. PMID 25850894 DOI: 10.1007/S11481-015-9605-1 |
0.693 |
|
| 2015 |
Walentiny DM, Vann RE, Wiley JL. Phenotypic assessment of THC discriminative stimulus properties in fatty acid amide hydrolase knockout and wildtype mice. Neuropharmacology. 93: 237-42. PMID 25698527 DOI: 10.1016/J.Neuropharm.2015.02.004 |
0.405 |
|
| 2015 |
Wiebelhaus JM, Grim TW, Owens RA, Lazenka MF, Sim-Selley LJ, Abdullah RA, Niphakis MJ, Vann RE, Cravatt BF, Wiley JL, Negus SS, Lichtman AH. Δ9-tetrahydrocannabinol and endocannabinoid degradative enzyme inhibitors attenuate intracranial self-stimulation in mice. The Journal of Pharmacology and Experimental Therapeutics. 352: 195-207. PMID 25398241 DOI: 10.1124/Jpet.114.218677 |
0.375 |
|
| 2014 |
Wiley JL, Walentiny DM, Wright MJ, Beardsley PM, Burston JJ, Poklis JL, Lichtman AH, Vann RE. Endocannabinoid contribution to Δ9-tetrahydrocannabinol discrimination in rodents. European Journal of Pharmacology. 737: 97-105. PMID 24858366 DOI: 10.1016/J.Ejphar.2014.05.013 |
0.622 |
|
| 2013 |
Adkins DE, McClay JL, Vunck SA, Batman AM, Vann RE, Clark SL, Souza RP, Crowley JJ, Sullivan PF, van den Oord EJ, Beardsley PM. Behavioral metabolomics analysis identifies novel neurochemical signatures in methamphetamine sensitization. Genes, Brain, and Behavior. 12: 780-91. PMID 24034544 DOI: 10.1111/Gbb.12081 |
0.679 |
|
| 2013 |
McClay JL, Adkins DE, Vunck SA, Batman AM, Vann RE, Clark SL, Beardsley PM, van den Oord EJ. Large-scale neurochemical metabolomics analysis identifies multiple compounds associated with methamphetamine exposure. Metabolomics : Official Journal of the Metabolomic Society. 9: 392-402. PMID 23554582 DOI: 10.1007/S11306-012-0456-Y |
0.695 |
|
| 2013 |
Walentiny D, Vann R, Mahadevan A, Kottani R, Gujjar R, Wiley J. Novel 3-substituted rimonabant analogues lack Δ(9) -tetrahydrocannabinol-like abuse-related behavioural effects in mice. British Journal of Pharmacology. 169: 10-20. PMID 23297801 DOI: 10.1111/Bph.12099 |
0.334 |
|
| 2012 |
Wiebelhaus JM, Poklis JL, Poklis A, Vann RE, Lichtman AH, Wise LE. Inhalation exposure to smoke from synthetic "marijuana" produces potent cannabimimetic effects in mice. Drug and Alcohol Dependence. 126: 316-23. PMID 22776442 DOI: 10.1016/J.Drugalcdep.2012.05.034 |
0.401 |
|
| 2012 |
Tobey KM, Walentiny DM, Wiley JL, Carroll FI, Damaj MI, Azar MR, Koob GF, George O, Harris LS, Vann RE. Effects of the specific α4β2 nAChR antagonist, 2-fluoro-3-(4-nitrophenyl) deschloroepibatidine, on nicotine reward-related behaviors in rats and mice. Psychopharmacology. 223: 159-68. PMID 22526534 DOI: 10.1007/S00213-012-2703-3 |
0.408 |
|
| 2012 |
Vann RE, Walentiny DM, Burston JJ, Tobey KM, Gamage TF, Wiley JL. Enhancement of the behavioral effects of endogenous and exogenous cannabinoid agonists by phenylmethyl sulfonyl fluoride. Neuropharmacology. 62: 1019-27. PMID 22051632 DOI: 10.1016/J.Neuropharm.2011.10.011 |
0.463 |
|
| 2011 |
Wiley JL, Matthew Walentiny D, Vann RE, Baskfield CY. Dissimilar cannabinoid substitution patterns in mice trained to discriminate Δ(9)-tetrahydrocannabinol or methanandamide from vehicle. Behavioural Pharmacology. 22: 480-8. PMID 21712709 DOI: 10.1097/Fbp.0B013E328348Eced |
0.374 |
|
| 2011 |
Walentiny DM, Gamage TF, Warner JA, Nguyen TK, Grainger DB, Wiley JL, Vann RE. The endogenous cannabinoid anandamide shares discriminative stimulus effects with ∆(9)-tetrahydrocannabinol in fatty acid amide hydrolase knockout mice. European Journal of Pharmacology. 656: 63-7. PMID 21300050 DOI: 10.1016/J.Ejphar.2011.01.056 |
0.381 |
|
| 2011 |
Wiley JL, Breivogel CS, Mahadevan A, Pertwee RG, Cascio MG, Bolognini D, Huffman JW, Walentiny DM, Vann RE, Razdan RK, Martin BR. Structural and pharmacological analysis of O-2050, a putative neutral cannabinoid CB(1) receptor antagonist. European Journal of Pharmacology. 651: 96-105. PMID 21114999 DOI: 10.1016/J.Ejphar.2010.10.085 |
0.313 |
|
| 2011 |
McClay JL, Adkins DE, Aberg K, Bukszár J, Khachane AN, Keefe RS, Perkins DO, McEvoy JP, Stroup TS, Vann RE, Beardsley PM, Lieberman JA, Sullivan PF, van den Oord EJ. Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 616-26. PMID 21107309 DOI: 10.1038/Npp.2010.193 |
0.559 |
|
| 2011 |
Vann RE, Tobey KM, Lobe SL, Kipps B, Kwilasz AJ, Aceto MD, Harris LS. Varenicline does not alter brain stimulation reward thresholds and reverses nicotine-facilitated thresholds in rats Drug Development Research. 72: 310-314. DOI: 10.1002/Ddr.20431 |
0.398 |
|
| 2010 |
Damaj MI, Grabus SD, Navarro HA, Vann RE, Warner JA, King LS, Wiley JL, Blough BE, Lukas RJ, Carroll FI. Effects of hydroxymetabolites of bupropion on nicotine dependence behavior in mice. The Journal of Pharmacology and Experimental Therapeutics. 334: 1087-95. PMID 20576796 DOI: 10.1124/Jpet.110.166850 |
0.399 |
|
| 2010 |
Jackson KJ, Marks MJ, Vann RE, Chen X, Gamage TF, Warner JA, Damaj MI. Role of alpha5 nicotinic acetylcholine receptors in pharmacological and behavioral effects of nicotine in mice. The Journal of Pharmacology and Experimental Therapeutics. 334: 137-46. PMID 20400469 DOI: 10.1124/Jpet.110.165738 |
0.354 |
|
| 2010 |
Walentiny DM, Vann RE, Warner JA, King LS, Seltzman HH, Navarro HA, Twine CE, Thomas BF, Gilliam AF, Gilmour BP, Carroll FI, Wiley JL. Kappa opioid mediation of cannabinoid effects of the potent hallucinogen, salvinorin A, in rodents. Psychopharmacology. 210: 275-84. PMID 20354680 DOI: 10.1007/S00213-010-1827-6 |
0.349 |
|
| 2009 |
Long JZ, Nomura DK, Vann RE, Walentiny DM, Booker L, Jin X, Burston JJ, Sim-Selley LJ, Lichtman AH, Wiley JL, Cravatt BF. Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo. Proceedings of the National Academy of Sciences of the United States of America. 106: 20270-5. PMID 19918051 DOI: 10.1073/Pnas.0909411106 |
0.391 |
|
| 2009 |
Kwilasz AJ, Harris LS, Vann RE. Removal of continuous nicotine infusion produces somatic but not behavioral signs of withdrawal in mice. Pharmacology, Biochemistry, and Behavior. 94: 114-8. PMID 19660491 DOI: 10.1016/J.Pbb.2009.07.015 |
0.4 |
|
| 2009 |
Vann RE, Warner JA, Bushell K, Huffman JW, Martin BR, Wiley JL. Discriminative stimulus properties of delta9-tetrahydrocannabinol (THC) in C57Bl/6J mice. European Journal of Pharmacology. 615: 102-7. PMID 19470387 DOI: 10.1016/J.Ejphar.2009.05.010 |
0.421 |
|
| 2009 |
Vann RE, Wise LE, Varvel SA, Philibin SD, Walentiny DM, Porter JH. Route of administration influences substitution patterns in rats trained to discriminate methadone vs. vehicle. Drug and Alcohol Dependence. 103: 124-30. PMID 19443130 DOI: 10.1016/J.Drugalcdep.2009.02.015 |
0.369 |
|
| 2008 |
Prus AJ, Vann RE, Rosecrans JA, James JR, Pehrson AL, O'Connell MM, Philibin SD, Robinson SE. Acute nicotine reduces and repeated nicotine increases spontaneous activity in male and female Lewis rats. Pharmacology, Biochemistry, and Behavior. 91: 150-4. PMID 18644403 DOI: 10.1016/J.Pbb.2008.06.024 |
0.394 |
|
| 2008 |
Pehrson AL, Philibin SD, Gross D, Robinson SE, Vann RE, Rosecrans JA, James JR. The effects of acute and repeated nicotine doses on spontaneous activity in male and female Sprague Dawley rats: analysis of brain area epibatidine binding and cotinine levels. Pharmacology, Biochemistry, and Behavior. 89: 424-31. PMID 18313740 DOI: 10.1016/J.Pbb.2008.01.018 |
0.365 |
|
| 2008 |
Vann RE, Gamage TF, Warner JA, Marshall EM, Taylor NL, Martin BR, Wiley JL. Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of Delta(9)-tetrahydrocannabinol. Drug and Alcohol Dependence. 94: 191-8. PMID 18206320 DOI: 10.1016/J.Drugalcdep.2007.11.017 |
0.396 |
|
| 2007 |
Robinson SE, Vann RE, Britton AF, O'Connell MM, James JR, Rosecrans JA. Cellular nicotinic receptor desensitization correlates with nicotine-induced acute behavioral tolerance in rats. Psychopharmacology. 192: 71-8. PMID 17235608 DOI: 10.1007/S00213-006-0687-6 |
0.401 |
|
| 2007 |
Vann RE, Cook CD, Martin BR, Wiley JL. Cannabimimetic properties of ajulemic acid. The Journal of Pharmacology and Experimental Therapeutics. 320: 678-86. PMID 17105826 DOI: 10.1124/Jpet.106.111625 |
0.418 |
|
| 2007 |
Britton AF, Vann RE, Robinson SE. Perinatal nicotine exposure eliminates peak in nicotinic acetylcholine receptor response in adolescent rats. The Journal of Pharmacology and Experimental Therapeutics. 320: 871-6. PMID 17105825 DOI: 10.1124/Jpet.106.112730 |
0.378 |
|
| 2006 |
Wright MJ, Vann RE, Gamage TF, Damaj MI, Wiley JL. Comparative effects of dextromethorphan and dextrorphan on nicotine discrimination in rats. Pharmacology, Biochemistry, and Behavior. 85: 507-13. PMID 17112574 DOI: 10.1016/J.Pbb.2006.09.020 |
0.438 |
|
| 2006 |
Vann RE, Rosecrans JA, James JR, Philibin SD, Robinson SE. Neurochemical and behavioral effects of bupropion and mecamylamine in the presence of nicotine. Brain Research. 1117: 18-24. PMID 16949560 DOI: 10.1016/J.Brainres.2006.07.110 |
0.429 |
|
| 2006 |
Vann RE, James JR, Rosecrans JA, Robinson SE. Nicotinic receptor inactivation after acute and repeated in vivo nicotine exposures in rats. Brain Research. 1086: 98-103. PMID 16626643 DOI: 10.1016/J.Brainres.2006.02.075 |
0.389 |
|
| 2006 |
Robinson SE, James JR, Lapp LN, Vann RE, Gross DF, Philibin SD, Rosecrans JA. Evidence of cellular nicotinic receptor desensitization in rats exhibiting nicotine-induced acute tolerance. Psychopharmacology. 184: 306-13. PMID 16010542 DOI: 10.1007/S00213-005-0049-9 |
0.423 |
|
| 2006 |
Vann RE, Balster RL, Beardsley PM. Dose, duration, and pattern of nicotine administration as determinants of behavioral dependence in rats. Psychopharmacology. 184: 482-93. PMID 16001123 DOI: 10.1007/S00213-005-0037-0 |
0.621 |
|
| 2005 |
Philibin SD, Vann RE, Varvel SA, Covington HE, Rosecrans JA, James JR, Robinson SE. Differential behavioral responses to nicotine in Lewis and Fischer-344 rats. Pharmacology, Biochemistry, and Behavior. 80: 87-92. PMID 15652384 DOI: 10.1016/J.Pbb.2004.10.009 |
0.388 |
|
| 2005 |
Porter JH, Prus AJ, Vann RE, Varvel SA. Discriminative stimulus properties of the atypical antipsychotic clozapine and the typical antipsychotic chlorpromazine in a three-choice drug discrimination procedure in rats. Psychopharmacology. 178: 67-77. PMID 15316715 DOI: 10.1007/S00213-004-1985-5 |
0.392 |
|
| 2002 |
Newman JL, Vann RE, May EL, Beardsley PM. Heroin discriminative stimulus effects of methadone, LAAM and other isomers of acetylmethadol in rats. Psychopharmacology. 164: 108-14. PMID 12373424 DOI: 10.1007/S00213-002-1198-8 |
0.64 |
|
| 2002 |
Dukat M, Damaj IM, Young R, Vann R, Collins AC, Marks MJ, Martin BR, Glennon RA. Functional diversity among 5-substituted nicotine analogs; in vitro and in vivo investigations. European Journal of Pharmacology. 435: 171-80. PMID 11821023 DOI: 10.1016/S0014-2999(01)01570-9 |
0.369 |
|
| 2000 |
Porter JH, Varvel SA, Vann RE, Philibin SD, Wise LE. Clozapine discrimination with a low training dose distinguishes atypical from typical antipsychotic drugs in rats. Psychopharmacology. 149: 189-93. PMID 10805615 DOI: 10.1007/S002139900366 |
0.363 |
|
| 2000 |
Porter JH, McCallum SE, Varvel SA, Vann RE. The discriminative stimulus properties of the atypical antipsychotic olanzapine in rats. Psychopharmacology. 148: 224-33. PMID 10755735 DOI: 10.1007/S002130050046 |
0.375 |
|
| 1999 |
Porter JH, Covington HE, Varvel SA, Vann RE, Warren TA. Chlorpromazine as a discriminative stimulus in rats: Generalization to typical and atypical antipsychotics Drug Development Research. 48: 38-44. DOI: 10.1002/(Sici)1098-2299(199909)48:1<38::Aid-Ddr5>3.0.Co;2-C |
0.371 |
|
| Show low-probability matches. |